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Conclusions: Infants below 3 years old are most susceptible
to HFMD. The peak season was May-July. EV71 infection
was associated with most of the critical casesof HFMD.
Hyperglycaemia, leucocytosis, pulmonary edema were the
prediction and risk factors of severe cases and should be
pay much attention to. EV71 combined inﬂuenza virus may
also contribute to the progress of the disease.
The seasonal distribution of 35 critical HFMD cases in 2009 and 2010.
Table: Clinical manifestation of 36 critical HFMD patients
Symptom/sign Number (%) of
patients (%)
Number (%) of
fatal cases
Fever 35 (97.2%) 18 (94.7%)
Peak temperature >39ºC 20 (55.6%) 10 (52.6%)
Duration of fever
0 l week 34 (94.4%) 16 (84.2%)
1 2 weeks 2 (5.6%) 2 (10.5%)
Skin rash
Hand 28 (77.8%) 12 (63.2%)
Foot 30 (83.3%) 15 (78.9%)
Mouth 25 (69.4%) 10 (52.6%)
Buttock 25 (69.4%) 14 (73.7%)
Upper limb 2 (5.6%) 1 (5.3%)
Lower limb 1 (2.8%) 1 (5.3%)
Vomiting 27 (75.0%) 15 (78.9%)
Myoclonus 17 (47.2%) 8 (42.1%)
Hyperarousal 13 (36.1%) 6 (31.6%)
Headache 2 (5.6%) 1 (5.3%)
Cough 6 (16.7%) 2 (10.5%)
Poor spirit 16 (44.4%) 9 (47.4%)
Anorexia 6 (16.7%) 7 (36.8%)
Lethargy 12 (33.3%) 7 (36.8%)
Twitch 7 (19.4%) 7 (36.8%)
Dysphagia 8 (22.2%) 5 (26.3%)
Dyspnea 2 (5.6%) 1 (5.26%)
Pulmonary rale 30 (83.3%) 15 (78.9%)
Abnormal tendon reﬂexes 17 (47.2%) 11 (57.9%)
Hypertension 2 (5.6%) 1 (5.26%)
Hypotension 3 (8.3%) 4 (21.1%)
Fast pulse 10 (27.8%) 8 (42.1%)
Shock 13 (36.1%) 9 (47.4%)
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PL-011 Hyper-activated pro-inﬂammatory CD16+
monocytes correlate with the severity of liver
injury and ﬁbrosis in patients with chronic
hepatitis B
F.-S. Wang1 *. 1Research Center for Biological Therapy
Beijing Institute of Infectious Diseases Beijing 302 Hospital,
China
Background: Extensive mononuclear cell inﬁltration is
strongly correlated with liver damage in patients with
chronic hepatitis B virus (CHB) infection. Macrophages and
inﬁltrating monocytes also participate in the development
of liver damage and ﬁbrosis in animal models. However,
little is known regarding the immunopathogenic role of
intrahepatic macrophages and monocytes.
Methods: The frequencies, phenotypes, and functions
of peripheral blood and intrahepatic monocyte subsets
were analyzed in 110 HBeAg positive CHB patients,
including 32 immune tolerant (IT) carriers and 78
immune activated (IA) patients. Liver biopsies from
20 IA patients undergoing diagnosis were collected for
immunohistochemical analysis.
Results: IA patients displayed signiﬁcant increases in
peripheral and intrahepatic monocytes as well as CD16+
subsets, which were closely associated with the liver
histological activity index (HAI) and serum alanine
aminotransferase (ALT) levels. Further analysis showed that
the increased CD16+ monocytes in the livers of IA patients
expressed high levels of the activation marker HLA-DR and
preferentially released inﬂammatory cytokines that not only
induced liver damage and ﬁbrosis but also that expanded
Th17 cells. Finally, hepatic neutrophils positively correlated
with HAI scores.
Conclusions: These distinct properties of monocyte
subpopulations participate in fostering the inﬂammatory
microenvironment and liver damage in CHB patients and
further represent a collaborative scenario among different
cell types contributing to the pathogenesis of HBV-induced
liver disease.
OL-080 Study on expression and dynamic changes of the
frequencies of regulatory T cells in HBV-related
acute-on-chronic liver failure patients
C. Li1 *, H.-F. Wang1. 1The 302 Hospital of People’s
Liberation Army, China
Objectives: To investigate clinical signiﬁcance of treg cells
in peripheral blood in HBV-related ACLF initial therapy
patients progression.
Methods: 44 cases of HBV-related ACLF patients, 46 cases
of chronic hepatitis B patients and 20 cases of healthy
control people were enrolled into their respective
groups. Flow cytometry was applied to detect the
frequencies of treg cells (CD4+CD25+Foxp3+), CD39+treg
cells (CD4+CD39+Foxp3+), and CTLA-4+treg cells (CD4+CTLA-
4+Foxp3+) in peripheral blood. HBV-related ACLF patients
were given a three weeks follow-up, the change trends of
the frequencies of treg cells, CD39+treg cells, CTLA-4+treg
cells in peripheral blood were observed dynamically.
Results: In HBV-related ACLF group, the frequencies of treg
cells (5.69%±1.83%), CD39+treg cells (49.55%±25.01%) and
CTLA-4+treg cells (35.27%±12.28%) in peripheral blood were
higher than those in chronic hepatitis B group (4.56%±1.59%,
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P < 0.01; 36.10%±20.65%, P < 0.01; 28.99%±10.59%, P < 0.01)
and in healthy control group (2.64%±0.42%, P < 0.01;
19.67%±9.09%, P < 0.01; 24.52%±7.52%, P < 0.01). The
frequencies of CD39+treg cells in peripheral blood in
HBV-related ACLF interim group (53.83%±26.62%, P < 0.05)
and late group (52.88% ±23.24%, P < 0.05) were higher
than those in early group (25.44%±8.73%). Eventually,
27 patients completed the dynamic observation in this short-
term follow-up, in improved group, MELD score showed a
gradually decreasing trend, the frequencies of treg cells
showed a gradually rising trend. But in deteriorated group,
MELD score showed a gradually rising trend, the frequencies
of treg cells showed a shortly rising and gradually decreasing
trend. In improved group and deteriorated group, the
frequencies of CD39+treg cells and CTLA-4+treg cells in
peripheral blood were not show signiﬁcant ﬂuctuations.
Conclusion: HBV-related ACLF patients suffered from an
immune imbalance, the expression and dynamic changes
the frequencies of treg cells in peripheral blood can be
used as additional tools in disease progression of clinical
observation and short-term prognosis prediction in those
patients.
OL-081 Vascular obstruction contributes to progression
of hepatic cirrhosis in patients with
chronic HBV
W.T. Li1 *, J.C. Yan2, C.J. Xu2, F.L. Chen2, S.N. Yuan2,
C.L. Zhu1, Y. Li1, R.T. Gao1. 1Department of Infectious
Disease, Anhui Provincial Hospital, Anhui Medical
University, 2Department of pathology, 123rd Hospital of
PLA, China
Objective: To investigate the relationship between Vascular
obstruction and progression of hepatic cirrhosis in patients
with chronic HBV.
Study design: 310 patients from 123rd hospital of PLA with
HBV-related cirrhosis received liver biopsy follow-up were
included in this study. HE and immunohistochemical staining
were used to examine the changed in liver pathology. The
scores of hepatic ﬁbrosis grading were determined blindly
by two independent pathologists.
Results: HE and Immunohistochemical staining demon-
strated that patients with high hepatic ﬁbrosis scores
showed intrahepatic vascular obstruction, more ﬁbrous
tissue and a stronger protein expression of VEGF in
endothelial cells compared with patients with low hepatic
ﬁbrosis scores. After intrahepatic injections with Hepatocyte
Growth Factor (HGF), vascular obstruction was markedly
ameliorated and collagen ﬁbers and expression of VEGF in
liver tissue was signiﬁcantly reduced showed by follow-up
liver biopsies compared with the initial liver biopsy.
Conclusions: Our data showed that vascular obstruction
contributes to progression of hepatic cirrhosis in patients
with chronic HBV. This study provided us a new therapeutic
approach to HBV-related liver cirrhosis.
Figure 1. Patients with liver cirrhosis (G4S4, HE × 100).
OL-082 Effect of SiRNA-mediated Smad3 silence on
proliferation and apoptosis in activated hepatic
stellate cells
L.X. Liu1 *, X.H. Guo1, Q.Q. Zhang1. 1The First Hospital of
Shanxi Medical University, China
Objectives: To investigate the effects of SiRNA mediated
Smad3 silence on proliferation, apoptosis in activated
hepatic stellate cells and the mechanisms involved.
Methods: HSC-T6 cells were divided into three groups: blank
group, negative control group, SiRNA-Smad3 transfection
group. The siRNA-Smad3 was transfected into HSC-T6 cells.
After transfecting with different time, cell proliferation was
measured by CCK-8, cell apoptosis was detected by ﬂow
cytometry, p53 and bcl-2 protein expression was detected
by immunocytochemistry.
Results: (1) After 24 h, 48 h, 72 h of transfection, HSC
proliferation was signiﬁcantly inhibited and apoptosis
increased signiﬁcantly in the transfection group compared
with the blank and negative control group (P < 0.01).
(2) After 48 h of transfection, the expression of p53
protein was increased signiﬁcantly and bcl-2 protein was
signiﬁcantly decreased in the transfection group compared
with the blank and negative control group (P < 0.01).
Conclusion: The Smad3-SiRNA mediated Smad3 silence can
signiﬁcantly inhibit HSC proliferation and induce apoptosis,
Smad3 silence inducing HSC apoptosis may be associated
with up-regulating expression of p53 and down-regulating
expression of bcl-2 on HSC. For the treatment of liver
ﬁbrosis, Smad3 silence may provide a new pathway.
Figure 1. Intrahepatic vascular obstruction in liver tissue (HE ×100).
OL-083 Autologous bone mesenchymal stem cell
transplantation in liver failure patients caused
by hepatitis B: 48-week observations of
therapeutic effects
L. Peng1 *, J. Liu1, Y.-B. Zheng1, Z.-L. Gao1. 1Department of
Infectious Diseases, 3rd Afﬁliated Hospital of Sun Yat-sen
University, China
Objectives: To investigate the therapeutic effects on liver
failure patients caused by hepatitis B at 48 weeks after
autologous MMSCs transplantation.
Methods: 53 patients (group A) underwent autologous
marrow mesenchymal stem cells (MMSCs) transplantation
and 105 patients with matched age, gender and biochemical
indexes, including alanine aminotransferase (ALT), albumin,
total bilirubin (TBIL), prothrombin time (PT), and Model for
End-Stage Liver Disease (MELD), comprised the group B who
received medical treatments only. 120ml of bone marrow
from patients were obtained and MMSC cell suspension were
separated and slowly transfused into the liver through the
proper hepatic artery. The side effects and complications
were observed. The manifestations of ultrasound and levels
of biochemical indexes were compared through 48 weeks.
